Von Willebrand factor (vWF) - cleaving protease

Details for Australian Patent Application No. 2012207034 (hide)

Owner Juridical Foundation the Chemo-SeroTherapeutic Research Institute

Inventors Nozaki, Chikateru; Maeda, Hiroaki; Nakagaki, Tomohiro; Soejima, Kenji; Hamamoto, Takayoshi; Mimura, Noriko

Agent FB Rice

Pub. Number AU-A-2012207034

Parent 2008243279

Filing date 17 July 2012

Wipo publication date 16 August 2012

International Classifications

A01K 67/027 Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 31/711 - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 38/46 Medicinal preparations containing peptides

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/16 Drugs for disorders of the alimentary tract or the digestive system

A61P 7/02 Drugs for disorders of the blood or the extracellular fluid

A61P 9/04 Drugs for disorders of the cardiovascular system

A61P 9/10 Drugs for disorders of the cardiovascular system

A61P 43/00 Drugs for specific purposes, not provided for in groups

C07K 16/40 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 1/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/50 Enzymes, e.g. ligases (6.) - Proteinases

C12N 9/64 Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/57 Mutation or genetic engineering - acting on peptide bonds (3.4)

C12Q 1/37 Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

A61K 38/00 Medicinal preparations containing peptides

Event Publications

9 August 2012 Complete Application Filed

16 August 2012 Application Open to Public Inspection

  Published as AU-A-2012207034

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012207035-Evaluating sprinkler head performance within a turf irrigation system

2012207033-Method of storing and picking